Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations

Theoretical Biology and Medical Modelling

Volumn 10, Issue 1, 2013, Pages

  Park, Hwangseo ^a   Yu, Keum Ran ^b   Ku, Bonsu ^b   Kim, Bo Yeon ^b   Kim, Seung Jun ^b  

^a Sejong University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Antiobestic agents; Docking; Inhibitor; PTPRQ; Virtual screening

Indexed keywords

ENZYME INHIBITOR; INOSITOL 3,4,5 TRISPHOSPHATE; INOSITOL 3,4,5-TRISPHOSPHATE; INOSITOL PHOSPHATE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CHEMISTRY; COMPUTER INTERFACE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVE SITE; HUMAN; HYDROLYSIS; IC 50; METABOLISM; MOLECULAR DOCKING;

CATALYTIC DOMAIN; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HUMANS; HYDROLYSIS; INHIBITORY CONCENTRATION 50; INOSITOL PHOSPHATES; MOLECULAR DOCKING SIMULATION; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; USER-COMPUTER INTERFACE;

EID: 84883111456     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-10-49     Document Type: Article

References (21)

1. Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. Heneberg P, Curr Med Chem 2009 16 706 733 10.2174/092986709787458407 19199933
2. Protein tyrosine phosphatases in the human genome. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T, Cell 2004 117 699 711 10.1016/j.cell.2004.05.018 15186772 (Pubitemid 38748887)
3. Protein tyrosine phosphatases-from housekeeping enzymes to master regulators of signal transduction. Tonks NK, FEBS J 2013 280 346 378 10.1111/febs.12077 23176256
4. PTPRQ is a novel phosphatidylinositol phosphatase that can be expressed as a cytoplasmic protein or as a subcellularly localized receptor-like protein. Seifert RA, Coats SA, Oganesian A, Wright MB, Dishmon M, Booth CJ, Johnson RJ, Alpers CE, Bowen-Pope DF, Exp Cell Res 2003 287 374 386 10.1016/S0014-4827(03) 00121-6 12837292 (Pubitemid 37323849)
5. Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation. Oganesian A, Poot M, Daum G, Coats SA, Wright MB, Seifert RA, Bowen-Pope DF, Proc Natl Acad Sci U S A 2003 100 7563 7568 10.1073/pnas.1336511100 12802008 (Pubitemid 36760009)
6. Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ. Goodyear RJ, Jones SM, Sharifi L, Forge A, Richardson GP, J Neurosci 2012 32 2762 2772 10.1523/JNEUROSCI.3635-11.2012 22357859
7. Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84. Shahin H, Rahil M, Abu Rayan A, Avraham KB, King MC, Kanaan M, Walsh T, J Med Genet 2010 47 643 645 10.1136/jmg.2009.075697 20472657
8. Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction. Schraders M, Oostrik J, Huygen PL, Strom TM, van Wijk E, Kunst HP, Hoefsloot LH, Cremers CW, Admiraal RJ, Kremer H, Am J Hum Genet 2010 86 604 610 10.1016/j.ajhg.2010. 02.015 20346435
9. Involvement of PTP-RQ in differentiation during adipogenesis of human mesenchymal stem cells. Jung H, Kim WK, Kim DH, Cho YS, Kim SJ, Park SG, Park BC, Lim HM, Bae KH, Lee SC, Biochem Biophys Res Comm 2009 383 252 257 10.1016/j.bbrc.2009.04.001 19351528
10. Structural basis for the dephosphorylating activity of PTPRQ towards phosphatidylinositide substrates. Yu KR, Kim YJ, Jung SK, Ku B, Park H, Cho SY, Jung H, Chung SJ, Bae KH, Lee SC, Kim BY, Erikson RL, Ryu SE, Kim SJ, Acta Crystallogr 2013 D69 1522 1529
11. A critical assessment of docking programs and scoring functions. Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS, J Med Chem 2006 49 5912 5931 10.1021/jm050362n 17004707 (Pubitemid 44484938)
12. Ligand solvation in molecular docking. Shoichet BK, Leach AR, Kuntz ID, Proteins 1999 34 4 16 10.1002/(SICI)1097-0134(19990101)34:1<4::AID- PROT2>3.0.CO;2-6 10336382 (Pubitemid 29019528)
13. Jeffrey GA, An introduction to hydrogen bonding Oxford: Oxford University Press 1997
14. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ, Adv Drug Deliver Rev 1997 23 3 25 10.1016/S0169- 409X(96)00423-1 (Pubitemid 27046991)
15. Iterative partial equalization of orbital electronegativity a rapid access to atomic charges. Gasteiger J, Marsili M, Tetrahedron 1980 36 3219 3228 10.1016/0040-4020(80)80168-2
16. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ, J Comput Chem 1998 19 1639 1662 10.1002/(SICI)1096- 987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B (Pubitemid 128590223)
17. Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Park H, Lee J, Lee S, Proteins 2006 65 549 554 10.1002/prot.21183 16988956 (Pubitemid 44583206)
18. Cubic equation governing the outer-region dielectric constant of globular proteins. Park H, Jeon JH, Phys Rev E 2007 75 021916
19. An effective solvation term based on atomic occupancies for use in protein simulations. Stouten PFW, Frömmel C, Nakamura H, Sander C, Mol Simul 1993 10 97 120 10.1080/08927029308022161
20. New solvation free energy function comprising intermolecular solvation and intramolecular self-solvation terms. Choi H, Kang H, Park H, J Cheminformatics 2013 5 8 10.1186/1758-2946-5-8
21. Selective inactivation of a human neuronal silencing phosphatase by a small molecule inhibitor. Zhang M, Cho EJ, Burstein G, Siegel D, Zhang Y, ACS Chem Biol 2011 6 511 519 10.1021/cb100357t 21348431